Total Compensation: $ 19.89 M
Richard T. Clark, Chairman of the Board (since April 2007), President and Chief Executive Officer (since May 2005), President, Merck Manufacturing Division (June 2003-May 2005) of the Company; Chairman, President (January 2000-December 2002) and Chief Executive Officer (January 2003-June 2003), Medco Health Solutions, Inc., formerly a wholly owned subsidiary of the Company Director, Project HOPE and United Negro College Fund; Chairman, Federal Health Care Legislation Committee of Pharmaceutical Research and Manufacturers of America; Trustee, Washington & Jefferson College and The Conference Board.
Total Compensation: $ 1.23 M
Effective August 14, 2007, the Board of Directors of Merck & Co., Inc. approved the election of Peter N. Kellogg to the office of Executive Vice President and Chief Financial Officer. Mr. Kellogg, who is 51 years old, currently serves as executive vice president and chief financial officer of Biogen Idec Inc. ("Biogen"), a biotechnology company, a position he has held since 2004. In that position, Mr. Kellogg is responsible for Biogen's worldwide finance function, with key responsibility for investor relationships, and accountable for Board review of financial performance, long-range plans, and all Board Finance and Audit Committee activities. Prior to that position, Mr. Kellogg held the same position at Biogen, Inc. - which merged with IDEC Pharmaceuticals in 2003.
Total Compensation: $ —
J. Chris Scalet, January, 2008 - Executive Vice President, Global Services, and Chief Information Officer ("CIO") - responsible for Global Shared Services across the human resources, finance, site services and information services function; and the enterprise business process redesign initiative; January, 2006 - Senior Vice President, Global Services, and CIO - responsible for Global Shared Services across the human resources, finance, site services and information services function; and the enterprise business process redesign initiative; March, 2003 - Senior Vice President, Information Services, and CIO - responsible for all areas of information technology and services including application development, technical support, voice and data communications, and computer operations worldwide; Prior to March 2003, Mr. Scalet was Senior Vice President, Information Technology & CIO (1997 to 2003) for International Paper Company (global forest products, paper and packaging company).
Total Compensation: $ —
Bruce N. Kuhlik, January, 2008 - Executive Vice President and General Counsel - responsible for legal, communications, and public policy functions and The Merck Company Foundation (a not-for-profit charitable organization affiliated with the Company); May, 2005 - Vice President and Associate General Counsel - primary responsibility for the Company's Vioxx litigation defense. Prior to May 2005, Mr. Kuhlik was Senior Vice President and General Counsel for the Pharmaceutical Research and Manufacturers of America since October, 2002.
Total Compensation: $ 5.85 M
Kenneth C. Frazier, August, 2007 - Executive Vice President and President, Global Human Health - responsible for the Company's marketing and sales organizations worldwide, including the global pharmaceutical and vaccine franchises; November, 2006 - Executive Vice President and General Counsel - responsible for legal and public affairs functions and The Merck Company Foundation (a not-for-profit charitable organization affiliated with the Company); December, 1999 - Senior Vice President and General Counsel - responsible for legal and public affairs functions and The Merck Company Foundation (a not-for-profit charitable organization affiliated with the Company).
Total Compensation: $ —
Willie A. Deese, January, 2008 - Executive Vice President and President, Merck Manufacturing Division ("MMD") - responsible for the Company's global manufacturing, procurement, and operational excellence functions; May, 2005 - President, Merck Manufacturing Division - responsible for the Company's global manufacturing, procurement, and operational excellence functions; January, 2004 - Senior Vice President, Global Procurement. Prior to January 2004, Mr. Deese was Senior Vice President, Global Procurement and Logistics (2001 to 2003) for GlaxoSmithKline plc.
Total Compensation: $ 6.50 M
Peter S. Kim, January, 2008 - Executive Vice President and President, Merck Research Laboratories ("MRL") - responsible for the Company's research and development efforts worldwide; January, 2003 - President, Merck Research Laboratories (MRL). February, 2001 - Executive Vice President, Research and Development, MRL.
Total Compensation: $ —
Celia A. Colbert, January, 2008 - Senior Vice President, Secretary; January, 1997 - Vice President, Secretary (since September, 1993) and Assistant General Counsel (since November, 1993) Responsible for Corporate Secretary function and Corporate Staff Group.
Total Compensation: $ —
John Canan, January, 2008 - Senior Vice President and Controller - responsible for the Corporate Controller's Group; September, 2006 - Vice President, Controller- responsible for the Corporate Controller's Group; June, 2003 - Vice President, Corporate Audit & Assurance Services; September, 2002 - Vice President and Controller, Asia and Joint Ventures - responsible for financial and operational oversight of Asia Human Health and several of the Company's joint ventures; August, 1999 - Controller, Asia Pacific Human Health.
Total Compensation: $ —
Mark E. Mcdonough, February, 2007 - Vice President and Treasurer - responsible for the Company's treasury function, and for providing financial support for Human Resources; January, 2004 - Assistant Treasurer, Global Capital Markets - responsible for managing the Company's investment and financing portfolios and the treasury share repurchase program; September, 2000 - Senior Director, Human Health Finance - responsible for providing global franchise-based financial reporting and analytics to Executive Committee and franchise and divisional stakeholders.
Total Compensation: $ —
Adele D. Ambrose, December, 2007 - Vice President and Chief Communications Officer - responsible for the Global Communications organization; April, 2005 - On sabbatical; Prior to April 2005, Ms. Ambrose was Executive Vice President, Public Relations & Investor Communications at AT&T Wireless (wireless services provider from September 2001 to April 2005).
Total Compensation: $ —
Adam H. Schechter, August, 2007 - President, Global Pharmaceuticals - global responsibilities for the Company's atherosclerosis/cardiovascular, diabetes/obesity, oncology, specialty/neuroscience, respiratory, bone, arthritis and analgesia franchises as well as commercial responsibility in the United States for the Company's portfolio of prescription medicines; July, 2006 - President, U.S. Human Health - commercial responsibility in the United States for the Company's portfolio of prescription medicines; October, 2005 - General Manager, U.S. Human Health Division - responsible for the Neuro-Psychiatry, Osteoporosis, Migraine, Respiratory, and New Products franchises; February, 2004 -Vice President/General Manager, Merck/Schering-Plough Pharmaceuticals U.S. Joint Venture; August, 2002 - Vice President, Merck Human Health Division, Arthritis & Analgesia Franchise Business Group.
Total Compensation: $ —
Peter C. Wendell, Managing Director, Sierra Ventures (technology-oriented venture capital firm) for more than five years; Chairman, Princeton University Investment Co. since 2002. Charter Trustee, Princeton University; Faculty, Stanford University Graduate School of Business.
Total Compensation: $ —
Steven F. Goldstone, 61, founder and managing partner, Silver Spring Group (private investment firm) for more than five years, will join the Company's Board of Directors effective Sept 25, 2007. Mr. Goldstone was retired chairman and chief executive officer of RJR Nabisco, Inc., one of the world's largest consumer products companies, from 1995 until his retirement five years later in 2000. Prior to that role, he was a partner at the New York law firm of Davis Polk & Wardwell from 1978 to 1995. He is currently the non-executive chairman of the Board of Directors of ConAgra Foods, Inc. He also serves on the boards of two other New York Stock Exchange-listed companies, Greenhill & Co. and American Standard Companies, Inc. Mr. Goldstone is chairman of the Founders Hall Foundation, Inc. and a trustee of the Aldrich Museum of Contemporary Art. He recently served as chairman of the Roundabout Theatre Company of New York and as an overseer at the University of Pennsylvania. A graduate of the University of Pennsylvania, Mr. Goldstone earned his law degree from New York University in 1970.
Total Compensation: $ —
Dr. Jacobson, Vice Chancellor, Health Affairs, Vanderbilt University Medical Center for more than five years. Director, CeleNova BioSciences, Inc., HealthGate Data Corporation, Ingram Industries, Inc. and Kinetic Concepts, Inc.; Member, American Society of Clinical Investigation, Association of American Physicians, Society of Medical Administrators, and Institute of Medicine. Dr. Jacobson earned his M.D. degree from the University of Illinois.
Total Compensation: $ —
Thomas H. Glocer, 48, Chief Executive Officer, Reuters Group PLC (global news and information company) for more than five years, will join the Company's Board of Directors effective Nov 27, 2007. With his election, Mr. Glocer will become one of 11 outside directors on the 12-member board. Mr. Glocer will stand for election by the Company's stockholders in April 2008. Mr. Glocer joined Reuters Group in New York in 1993 and was appointed Chief Executive Officer of Reuters America in 1999. In February 2000, he was appointed Chief Executive Officer, Reuters Information, and was appointed to the Reuters Board in June of that same year. Mr. Glocer was named Chief Executive Officer of Reuters Group PLC in July 2001. Prior to joining Reuters, Mr. Glocer was a mergers and acquisitions lawyer with Davis Polk & Wardwell in New York, Paris and Tokyo. Mr. Glocer is a member of the International Advisory Board of British American Business Inc., the Advisory Board of the Judge Institute of Management at Cambridge University, the European Business Leaders Council, the Corporate Advisory Group of Tate Britain and The Madison Council of the Library of Congress. He is also active in several public education initiatives in New York City and London. A graduate of Columbia University, Mr. Glocer earned a bachelor's degree in political science. He earned his law degree from Yale Law School.
Total Compensation: $ 3.95 M
—
Total Compensation: $ —
Dr. William N. Kelley, M.D.,Professor of Medicine, Biochemistry and Biophysics, University of Pennsylvania School of Medicine for more than five years. Director, Advanced Bio-Surfaces, Inc., Beckman Coulter, Inc., GenVec, Inc. and Polymedix, Inc.; Fellow, American Academy of Arts and Sciences; Master, American College of Physicians and American College of Rheumatology; Member, American Philosophical Society and Institute of Medicine of the National Academy of Sciences; Trustee, Emory University.
Total Compensation: $ —
August, 2006 - Vice President, Public Affairs. Prior to August 2006, Mr. Kelmar led the global public affairs and communications function at Novartis AG since 2002.
Total Compensation: $ —
Dr. Thomas E. Shenk, Ph.D., Elkins Professor (since 1984) and Chairman (1996-2004), Department of Molecular Biology, Princeton University. Director, Cell Genesys, Inc. and CV Therapeutics, Inc.; Fellow, American Academy of Arts and Sciences; Member, American Academy of Microbiology and National Academy of Sciences and its Institute of Medicine.
Total Compensation: $ —
Stefan Oschmann, September, 2006 - President, Europe, Middle East, Africa & Canada; October, 2005 - Senior Vice President, Worldwide Human Health Marketing; January, 2001 - Managing Director, MSD Germany, a subsidiary of the Company.
Total Compensation: $ —
Wendy L. Yarno, August, 2007 - Chief Marketing Officer - responsible for the global human health commercial operations support organization, including the Company's Global Human Health Business Process and Program Management, Global Marketing Support, Global Medical Affairs, Global Product Access and Outcomes Research, and Global Alliance Management and New Product Licensing; September, 2006 - Chief Marketing Officer - responsible for Global Marketing Services, Global Alliance Management and Global Pricing, Global Human Health Business Practices & Compliance and three franchises: Oncology, Specialty and Neuroscience; Respiratory, Bone and Arthritis and Analgesia; and Infectious Diseases and Hospital Products; November, 2005 - General Manager, Business Unit 3, U.S. Human Health; January, 2003 - Executive Vice President, Worldwide Human Health Marketing.
Total Compensation: $ —
Wendell P. Weeks, Chairman and Chief Executive Officer (since April 2007), President and Chief Executive Officer (April 2005-April 2007), President and Chief Operating Officer (April 2002-April 2005), Corning Incorporated (technology company in the telecommunications, information display and advanced materials industries). Director, Corning Incorporated; Trustee, Lehigh University.
Total Compensation: $ —
William B. Harrison, Jr., Retired Chairman of the Board (since December 31, 2006), prior to which he was Chairman (from November 2001) and Chief Executive Officer (from November 2001 until December 2005), JPMorgan Chase & Co. (financial services) Director, Cousins Properties Incorporated; Member, The Business Council, The Financial Services Forum, The Financial Services Roundtable and The Institute of International Economics.
Total Compensation: $ 4.76 M
David W. Anstice, September, 2006 - Executive Vice President, Strategy Initiatives - responsible for the End-to-End and global support function initiatives and for providing strategic direction in key pharmaceutical emerging markets (China and India); August, 2005 - President, Human Health-Asia Pacific - responsible for the Company's prescription drug business in the Asia Pacific region, Japan, Australia, New Zealand and the Company's joint venture relationship with Schering-Plough; January, 2003 - President, Human Health - responsible for the Company's prescription drug business in Japan, Latin America, Canada, Australia, New Zealand and the Company's joint venture relationship with Schering-Plough; March, 2001 - President, The Americas and U.S. Human Health - responsible for one of the two prescription drug divisions comprising U.S. Human Health, as well as the Company's prescription drug business in Canada and Latin America, and the Company's joint venture relationship with Schering-Plough. January, 1997 - President, Human Health - The Americas - responsible for the Company's human health business in the United States, Canada and Latin America.
Total Compensation: $ —
Dr. Johnnetta B. Cole, Ph.D., President Emerita of Spelman College and Bennett College for Women; President, Bennett College for Women (July 2002 through May 2007); Chairman, The JBC Institute for Global Diversity and Inclusion; Member and Past Chair, Board of Trustees, United Way of America; Member, Council on Foreign Relations and National Council of Negro Women; Fellow, American Academy of Arts and Sciences and American Anthropological Association.
Total Compensation: $ —
Margaret G. McGlynn, August, 2007 - President, Merck Vaccines and Infectious Diseases - global responsibilities for the vaccines business and infectious diseases franchise including the Company's Sanofi-Pasteur joint venture; August, 2005 - President, Merck Vaccines - global responsibilities for the vaccines business including the Company's Sanofi-Pasteur joint venture; January, 2003 - President, U.S. Human Health - responsible for one of the two prescription drug divisions (hospital and specialty product franchises) comprising U.S. Human Health (USHH), and the Managed Care Group of USHH. August, 2001 - Executive Vice President, Customer Marketing and Sales, USHH. November, 1998 - Senior Vice President, Worldwide Human Health Marketing.
Total Compensation: $ —
Dr. Samuel O. Thier, M.D., Professor of Medicine and Health Care Policy, Emeritus (since 2008), Professor of Medicine and Professor of Health Care Policy (1994-2007), Harvard Medical School. Director, Charles River Laboratories, Inc.; Fellow, American Academy of Arts and Sciences; Master, American College of Physicians; Member, Board of Overseers, Teachers Insurance and Annuity Association of America-College Retirement Equities Fund and Cornell University Weill Medical College.
Total Compensation: $ —
Rochelle B. Lazarus, Chairman and Chief Executive Officer, Ogilvy & Mather Worldwide (advertising and marketing communication company) for more than five years. Director, General Electric, New York Presbyterian Hospital, American Museum of Natural History and World Wildlife Fund; Member, Advertising Education Foundation and Board of Overseers, Columbia Business School.
Total Compensation: $ —
Dr. Mirian M. Graddick-Weir, January, 2008 - Executive Vice President, Human Resources - responsible for the Global Human Resources organization; September, 2006 - Senior Vice President, Human Resources. Prior to September 2006, Dr. Graddick-Weir was Executive Vice President of Human Resources and Employee Communications at AT&T, and has held several other senior Human Resources leadership positions at AT&T for more than 20 years (communications services provider).
Total Compensation: $ —
Anne M. Tatlock, Retired; Chairman of the Board (from June 2000 until December 31, 2006) and Chief Executive Officer (from September 1999 until December 31, 2006), Fiduciary Trust Company International (global asset management services). Director, Fortune Brands, Inc. and Franklin Resources, Inc.; Chairman, The Andrew W. Mellon Foundation; Fellow, American Academy of Arts and Sciences; Member, Council on Foreign Relations; Trustee, American Ballet Theatre Foundation, The Conference Board, Howard Hughes Medical Institute, The Mayo Foundation and The World Trade Center Memorial Foundation.
